AusPAR: Idarucizumab

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

8 November 2016
AusPAR Details
AusPAR
AusPAR Idarucizumab (pdf, 747 KB)
AusPAR Idarucizumab (docx, 642 KB)
Attachment: Product Information: Idarucizumab (pdf, 357 KB)
Attachment: Product Information: Idarucizumab (docx, 982 KB)
Attachment: Extract from Clinical Evaluation Report: Idarucizumab (pdf, 1 MB)
Attachment: Extract from Clinical Evaluation Report: Idarucizumab (docx, 3 MB)
Active Ingredient
Idarucizumab
Product Name
Praxbind
Sponsor
Boehringer Ingelheim Pty Ltd
Submission Number
PM-2015-00707-1-3
Submission Type
New biological medicine
Decision
Approved
AusPAR Date
25 October 2016
Publication Date

8 November 2016
URL: 
https://www.tga.gov.au/node/732550